Amylyx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Name: Amylyx Pharmaceuticals Inc: Is Infosys Ltd. worth buying?
Item: Amylyx Pharmaceuticals Inc
Rating: 1.99141675
Author: Trendlyne DVM scores

about

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...

14.30 0.78 (5.77%)

450.00% Gain from 52W Low

1.7M

XNAS Volume

XNAS 16 Jan, 2026 4:30 PM (EST)

Not Eligible

Expensive Valuation

6.2 / 100

Technically Bullish

73.5 / 100

1Yr Price target upside is 41%

9 analysts

Amylyx Pharma Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Amylyx Pharma Inc Live Stock Price Today, Share Analysis and Chart

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching ...

450.00% Gain from 52W Low

SWOT Analysis

Amylyx Pharma Inc Live Price Chart